SEC Company Response from PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981) (CNSY) — Sep 20, 2019
PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981)
Date: Sept. 20, 2019 · CIK: 0001095981 · Accession: 0001564590-19-035151
AI Filing Summary & Sentiment
File numbers found in text: 333-229485
Show Raw Text
CORRESP 1 filename1.htm pstv-corresp.htm September 20, 2019 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Re: PLUS THERAPEUTICS, INC. Registration Statement on Form S-1 (Registration No. 333-229485) Concurrence in Acceleration Request Ladies and Gentlemen: H.C. Wainwright & Co., LLC (“Wainwright”), as managing underwriter for the above-referenced offering, hereby concurs in the request by Plus Therapeutics, Inc. that the effective date of the above-referenced registration statement be accelerated to 12:00 P.M. Eastern Time on Monday, September 23, 2019, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering. Very truly yours, H.C. WAINWRIGHT & CO., LLC By: __/s/ Edward D. Silvera____ Name: Edward D. Silvera Title: Chief Operating Officer 430 Park Avenue | New York, New York 10022 | 212.356.0500 Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC